Arca
Skip to content
Tools
Tools

Avaira Vitality

Lenses, Soft Contact, Daily Wear. 510(k) K213164, from CooperVision, Inc. (San Ramon, CA). Product code LPL, class 2.

As of Nov 18, 2026, K213164 is an FDA 510(k) held by CooperVision, Inc., substantially equivalent on Oct 26, 2021 after 28 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 28 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Sphere/Asphere: AVAIRA VITALITY SPHERE and ASPHERE (fanfilcon A) Soft Contact lenses are indicated for the correction of ametropia (myopia and hyperopia) in aphakic and non-aphakic persons with non-diseased eyes in powers from -20.00 to +20.00 diopters. The lenses may be worn by persons who exhibit astigmatism of 2.00 diopters or less that does not interfere with visual acuity.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K213164, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Sep 22, 2026Z-0204-2027The affected products bear an incorrect statement on the carton packaging indicating that the product is "Indicated for Extended Wear". However, this product is intended for daily wear, and the extended-wear statement…Open

Other LPL clearances

The newest 510(k)s for the same product code; their median review was 146 days; see every LPL device

Record

Type
Special
Received
Sep 28, 2021
Review panel
Ophthalmic
Regulation
21 CFR 886.5925

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.